✦ LIBER ✦

Skin rash by gefitinib is a sign of favorable outcomes for patients of advanced lung adenocarcinoma in Japanese patients

✍ Scribed by Yasoo Sugiura, Etsuo Nemoto, Osamu Kawai, Yasuyuki Ohkubo, Hisae Fusegawa…

Book ID: 120798161
Publisher: Springer
Year: 2013
Tongue: English
Weight: 164 KB
Volume: 2
Category: Article
ISSN: 2193-1801
DOI: 10.1186/2193-1801-2-22

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Osteosclerotic lesions in patients treat

Osteosclerotic lesions in patients treated with gefitinib for lung adenocarcinomas: a sign of favorable therapeutic response

✍ Yoshiko Yamashita; Takatoshi Aoki; Takeshi Hanagiri; Chiharu Yoshii; Hiroshi Muk 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 283 KB

9123 POSTER Final Results of a Phase II

9123 POSTER Final Results of a Phase II Study of Gefitinib as First-line Treatment in Elderly Epidermal Growth Factor Receptor-mutated Patients With Advanced Non-small Cell Lung Cancer – Gefitinib for Elderly Patients With Lung Adenocarcinoma

✍ Asami, K.; Koizumi, T.; Hirai, K.; Ameshima, S.; Tsukadaira, A.; Morozumi, N.; M 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 43 KB

The epidermal growth factor receptor int

The epidermal growth factor receptor intron1 (CA) n microsatellite polymorphism is a potential predictor of treatment outcome in patients with advanced lung cancer treated with Gefitinib

✍ Qiang Nie; Zhen Wang; Guo-chun Zhang; She-juan An; Jia-yin Lin; Ai-lin Guo; Rong 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 255 KB

Randomized Phase III Trial of Platinum-D

Randomized Phase III Trial of Platinum-Doublet Chemotherapy Followed by Gefitinib Compared With Continued Platinum-Doublet Chemotherapy in Japanese Patients With Advanced Non-Small-Cell Lung Cancer: Results of a West Japan Thoracic Oncology Group Trial (WJTOG0203)

✍ Takeda, K.; Hida, T.; Sato, T.; Ando, M.; Seto, T.; Satouchi, M.; Ichinose, Y.; 📂 Article 📅 2010 🏛 American Society of Clinical Oncology 🌐 English ⚖ 228 KB

1015 Abnormal P-53 suppressor gene expre

1015 Abnormal P-53 suppressor gene expression predicts for a poorer outcome in patients with locally advanced adenocarcinoma of the prostate treated by external beam radiation therapy with or without pre-radiation androgen ablation: Results based on RTOG study 86-10

✍ Colleen A. Lawton; David Grignon; Richard Caplan; Fazlul Sarkar; Jeffrey Forman; 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 88 KB